Ohizumi Y, Takahashi M, TOBE A
Br J Pharmacol. 1982; 75(2):377-82.
PMID: 7186825
PMC: 2071607.
DOI: 10.1111/j.1476-5381.1982.tb08797.x.
Genovese A, Chiariello M, De Alfieri W, Latte S, Condorelli M
Basic Res Cardiol. 1983; 78(3):289-97.
PMID: 6615401
DOI: 10.1007/BF01907438.
Izquierdo I, Dias R
Psychopharmacology (Berl). 1983; 80(2):181-3.
PMID: 6136062
DOI: 10.1007/BF00427966.
Broadley K, Roberts D
Br J Pharmacol Chemother. 1967; 31(1):169-77.
PMID: 6055251
PMC: 1557280.
DOI: 10.1111/j.1476-5381.1967.tb01987.x.
Gillespie J, Muir T
Br J Pharmacol Chemother. 1967; 30(1):99-107.
PMID: 6039976
PMC: 1557244.
DOI: 10.1111/j.1476-5381.1967.tb02116.x.
Differential effects of tetrodotoxin on sympathomimetic actions of nicotine and tyramine.
Bell C
Br J Pharmacol Chemother. 1968; 32(1):96-103.
PMID: 5689116
PMC: 1570294.
DOI: 10.1111/j.1476-5381.1968.tb00433.x.
The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
Rand M, Trinker F
Br J Pharmacol Chemother. 1968; 33(2):287-303.
PMID: 5664149
PMC: 1570221.
DOI: 10.1111/j.1476-5381.1968.tb00990.x.
Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine.
AVIADO D, Sadavongvivad C
Br J Pharmacol. 1970; 38(2):374-85.
PMID: 5417860
PMC: 1702789.
DOI: 10.1111/j.1476-5381.1970.tb08525.x.
Possible peripheral adrenergic and cholinergic mechanisms in pseudoconditioning.
Izquierdo I
Psychopharmacologia. 1974; 35(3):189-93.
PMID: 4829321
DOI: 10.1007/BF00437747.
Effect of tyramine on human umbilical artery in vitro.
Gulati O, Kelkar V
Br J Pharmacol. 1971; 42(1):155-8.
PMID: 4397171
PMC: 1666998.
DOI: 10.1111/j.1476-5381.1971.tb07096.x.
Cardiostimulatory effects of oxyfedrine, DMPP and sympathomimetics in relation to their 3H-noradrenaline-releasing properties.
Kukovetz W, Poch G
Naunyn Schmiedebergs Arch Pharmakol. 1971; 268(1):59-70.
PMID: 4395352
DOI: 10.1007/BF00997173.
The effect of orally administered cocaine on sleep of depressed patients.
Post R, Gillin J, Wyatt R, Goodwin F
Psychopharmacologia. 1974; 37(1):59-66.
PMID: 4370448
DOI: 10.1007/BF00426683.
[Vasoactive substances belonging to the body and pharmacologic agents with peripheral point of application].
Muscholl E
Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1967; 188(1):84-114.
PMID: 4297961
Mechanisms of reflex vasodilation: assessment of the role of neural reuptake of norepinephrine and release of histamine.
Glick G, Wechsler A, Epstein S
J Clin Invest. 1968; 47(3):511-20.
PMID: 4170148
PMC: 297197.
DOI: 10.1172/JCI105747.
Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment.
Keith R, Salama A
Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(4):412-9.
PMID: 2885761
DOI: 10.1007/BF00165556.
The effect of adrenaline, tyramine and guanethidine on two-way avoidance conditioning and on pseudoconditioning.
Izquierdo I, Thaddeu R
Psychopharmacologia. 1975; 43(1):85-7.
PMID: 1161996
DOI: 10.1007/BF00437620.
The sympathomimetic activity of fenfluramine hydrochloride on rat vas deferens.
Mottram D, Wadhwani D
Br J Pharmacol. 1977; 59(4):615-20.
PMID: 870124
PMC: 1667758.
DOI: 10.1111/j.1476-5381.1977.tb07729.x.
EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.
Consroe P, Jones B, Laird 2nd H
Psychopharmacology (Berl). 1976; 50(1):47-52.
PMID: 827761
DOI: 10.1007/BF00634153.
